Vol. 10 No. 3 (2022)

Published: 2023-11-09

Articles

  • "COMPARING THE IMPACT OF INSULIN DEGLUDEC AND NPH INSULIN IN TYPE 1 DIABETES"
    Dr. Keiko Kobayashi, Dr. Yusuke Sakamoto , Prof. Naoko Inoue

    Type 1 diabetes mellitus (T1DM) is a condition characterized by the autoimmune or idiopathic destruction of pancreatic ß-cells, resulting in insulin deficiency. To manage T1DM, patients require insulin replacement therapy, with basal-bolus insulin injection being the mainstay of treatment. While

    1-11
  • EVALUATING THE INFLUENCE OF BASELINE DIABETES KNOWLEDGE
    Dr. Jennifer A. Davis , Dr. Michael T. Thompson

    Diabetes is a pressing public health concern, with a continuous rise in its prevalence, impacting approximately 9.4% of the U.S. population. If current trends persist, projections suggest that diabetes could affect one in three U.S. adults by 2050, further emphasizing the urgency of effective

    38-47
  • FROM RESISTANCE TO RESILIENCE: MIIDEA'S IMPACT ON DIABETES MANAGEMENT"
    Dr. Emily Mitchell, Prof. Daniel Williams , Dr. Rebecca Turner

    In the United States, a significant portion of the population, around 24%, is on a daily regimen of three or more medications, a number that tends to be even higher among individuals grappling with chronic conditions like diabetes. The adherence to medication regimens shows an inverse

    12-21
  • "SCHIZOPHRENIA AND QUALITY OF LIFE: DISSECTING THE NEXUS"
    Prof. Luiz Carlos Pereira , Dr. Carlos Eduardo Alves

    Schizophrenia is a debilitating and complex syndrome that affects around 1% of the global population, ranking among the top ten most disabling diseases according to the World Health Organization. This chronic condition significantly impacts the quality of life for individuals afflicted by it,

    22-37